Pay in 4 interest-free payments of $5.91 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Large-scale clinical trials have demonstrated that GLP-1RAs predominantly exhibit neutral or suppressive effects on overall cancer risk, with semaglutide showing no elevated cancer incidence [14], while significant reductions have been observed in specific malignancies, particularly liver cancers and prostate cancers [13, 15]
Key Ingredients
In 2017, Novo Nordisk brought semaglutide to market in the U.S., under the brand name Ozempic
Insulin-like Growth Factor 1 Long Arg3 (IGF-1 LR3) is a powerful peptide widely recognized for its benefits in promoting muscle growth, recovery, and even neuroprotection
US$ 21.51
US$ 25.05
US$ 25.19
